Report
Lundbeck is reportedly interested in buying Xeris Biopharma
Bloomberg, citing people familiar with the matter, reports that Lundbeck has expressed interest in acquiring Xeris Biopharma, a commercial-stage drugmaker.
TLDR
Lundbeck has expressed interest in acquiring Xeris Biopharma, Bloomberg reports, citing people familiar with the matter. Xeris is a commercial-stage drugmaker.
Combined views
35.4K
1 Source, first seen 3h ago
2 likes